CDSCO Panel revises warning statement of Sanofi's antidiabetic FDC Insulin Glargine plus Lixisenatide Dr. Divya Colin13 Dec 2023 6:00 PM ISTNew Delhi: Approving the amendment in the warning statement for Sanofi's Fixed Ratio Combination of Insulin Glargine 100U/mL plus Lixisenatide 50...
Sanofi terminates deal to exclusively license Maze Therapeutics Pompe disease drug Ruchika Sharma12 Dec 2023 2:30 PM ISTWashington: Sanofi has said it was terminating a deal to exclusively license a drug that Maze Therapeutics is developing to treat Pompe disease...
Sarclisa plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone: Sanofi Ruchika Sharma11 Dec 2023 2:30 PM ISTParis: Sanofi has announced that the Phase 3 trial investigating Sarclisa (isatuximab) in combination with carfilzomib, lenalidomide and...
Sanofi multiple myeloma drug Sarclisa phase 3 trial meets primary endpoint of progression-free survival Ruchika Sharma10 Dec 2023 11:30 AM ISTParis: Sanofi has announced that the Phase 3 IMROZ trial evaluating the investigational use of Sarclisa (isatuximab) in combination with...
Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline Ruchika Sharma8 Dec 2023 1:30 PM ISTNew Delhi: Sanofi said on Thursday it will focus on 12 potential blockbuster drug candidates and prioritise development in immunology, as it...
Sanofi plans to seek US nod for Dupixent as COPD treatment Ruchika Sharma28 Nov 2023 1:30 PM ISTUsing Dupixent for COPD could add billions to the French drugmaker's growth prospects.
Autistic children mother lodges complaint over emissions from Sanofi Depakine drug plant: Report Ruchika Sharma21 Nov 2023 12:30 PM ISTParis: The mother of two autistic children in France has lodged a legal complaint for endangering life after she suspected she was exposed to airborne...
Sanofi completes closing for potential vaccine against extraintestinal pathogenic E.coli Ruchika Sharma12 Nov 2023 5:00 PM ISTParis: Sanofi has announced the completion of closing for its collaborative agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson...
Sanofi probed for possible market manipulation by French prosecutor: Source Ruchika Sharma9 Nov 2023 4:52 PM ISTParis: French financial prosecutors have opened a preliminary probe into drugmaker Sanofi over possible share price manipulation, a person...
Sanofi considers listing consumer unit late next year Ruchika Sharma30 Oct 2023 2:30 PM ISTNew Delhi: Sanofi has mapped out a separate listing of its consumer healthcare business from the fourth quarter of next year, the French drugmaker...
GoodRx to offer Sanofi insulin injection Lantus for only USD 35 in US Ruchika Sharma24 Oct 2023 10:00 AM ISTUnited States: GoodRx has said it has collaborated with Sanofi to offer the drugmaker's most-prescribed insulin injection Lantus for only $35...
Require additional efficacy data for Dupixent approval for chronic spontaneous urticaria: USFDA to Sanofi Ruchika Sharma23 Oct 2023 4:44 PM ISTDupixent is a fully human monoclonal antibody that inhibits the signaling of the IL-4 and IL-13 pathways and is not an immunosuppressant.
